Darren Kies, MD
Vascular & Interventional Radiology · Atlanta, GANPI 1194922120
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Terumo Medical Corporation at 52.4% of the total. Reporting peaked in 2019 at $7,561 and has fallen 96.1% since, to $294 in 2025.
Across 89 payments — averaging $158.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Terumo Medical Corporation$7K
- Trisalus Life Sciences, Inc.$4K
- Sirtex Medical Inc$661
- Medtronic$441
- Boston Scientific$279
- Biocompatibles, Inc.$197
- plus $729 from 12 others
What the payments were for
- Consulting fees$6,30045%
- Speaking & faculty fees$1,2009%
- Travel & lodging$2,37017%
- Food & beverage$4,21730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Terumo Medical Corporation | 10 | $7,380 |
| Trisalus Life Sciences, Inc. | 33 | $4,399 |
| Sirtex Medical Inc | 13 | $661 |
| Medtronic(2 entities) | 12 | $441 |
| Boston Scientific | 4 | $279 |
| Biocompatibles, Inc. | 2 | $197 |
| Galvanize Therapeutics, Inc | 1 | $131 |
| Genentech, Inc. | 1 | $114 |
| Varian Medical Systems, Inc. | 2 | $97 |
| GE HealthCare | 2 | $85 |
| Avanos Medical | 1 | $83 |
| Bard Peripheral Vascular, Inc. | 2 | $74 |
| Stryker | 1 | $32 |
| Ethicon Endo-surgery Inc. | 1 | $32 |
| Siemens Medical Solutions USA, Inc. | 1 | $29 |
| Johnson & Johnson | 1 | $22 |
| Balt USA, LLC | 1 | $16 |
| W. L. Gore & Associates, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Navicross$6,199
- TR Band$6,199
- Glidesheath$6,199
- GlideWire$6,199
- TRINAV INFUSION SYSTEM$3,803
- SIR-Spheres Microspheres$416
- Azur CX Detachable$265
- KYPHON EXPRESS II KYPHOPAK TRAY$164
- GENERAL - THERAPIES$161
- THERASPHERE-BIO$150
- ALIYA SYSTEM$131
- OSTEOCOOL RF ABLATION$125
- AZUR$111
How this compares
$14,087 in reported general payments places this provider in the 75th percentile of 120 vascular & interventional radiology providers in Georgia.
See all vascular & interventional radiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $109 |
| Ciprofloxacin Hcl | 11 | $55 |
| Oxycodone Hcl | 11 | $53 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Atlanta
- Nima KokabiAtlanta$1M
- Jason LevyAtlanta$822K
- Aravind ArepallyAtlanta$249K
- Kei YamadaAtlanta$154K
- Kirema Garcia-ReyesAtlanta$115K
- John PrologoAtlanta$97K
- Jonathan MartinAtlanta$82K
- Steven CitronAtlanta$66K
- Kevin CarsonAtlanta$37K
- Jun Man KimAtlanta$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.